Europa Biosite has announced that Bio X Cell has appointed Cambridge Bioscience, a member of Europa Biosite, as its exclusive distributor for the United Kingdom and Ireland.
Eppendorf has announced the commercial launch of the Eppendorf Research 3 neo, designed to deliver accurate and precise results for accelerated volume selection, and optimised ergonomics.
Gifthealth has announced its acquisition of Occam Health Services creating the "first-of-its-kind" digital pharmacy platform and patient access hub solution.
Lubrizol will showcase the benefits of its polymer-based excipients for the solubility, bioavailability and palatability of APIs and nutraceuticals at CPHI Frankfurt (28th- 30th October 2025 at Stand 8.0M71).
Polpharma Biologics has announced that it has signed licensing agreements with MS Pharma for the commercialisation of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.
CN Bio, a provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, has announced the expansion of its Contract Research Services (CRS) with new PhysioMimix computational modelling tools.
TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, has announced the formation of its Scientific Advisory Board (SAB).
Aptamer, the developer of next-generation synthetic binders for the life sciences industry, has announced that it has signed a new therapeutic development agreement with Invizius.
Qureight has announced the appointment of Craig Rhodes as head of partnerships to lead strategic engagements with pharmaceutical organisations, in line with Qureight’s revenue growth targets.
The Guardtech Group are shortlisted for the Large Pharma Project at the Pharma Industry Awards at the Park Plaza London Riverbank on Wednesday 10th September.
